Rights statement: © 2016 The Authors Bioethics Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Final published version, 172 KB, PDF document
Available under license: CC BY: Creative Commons Attribution 4.0 International License
Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Should deceased donation be morally preferred in uterine transplantation trials?
AU - Williams, Nicola
N1 - © 2016 The Authors Bioethics Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
PY - 2016/7
Y1 - 2016/7
N2 - In recent years much research has been undertaken regarding the feasibility of the human uterine transplant (UTx) as a treatment for absolute uterine factor infertility (AUFI). Should it reach clinical application this procedure would allow such individuals what is often a much-desired opportunity to become not only social mothers (via adoption or traditional surrogacy arrangements), or genetic and social mothers (through gestational surrogacy) but mothers in a social, genetic and gestational sense. Like many experimental transplantation procedures such as face, hand, corneal and larynx transplants, UTx as a therapeutic option falls firmly into the camp of the quality of life (QOL) transplant, undertaken with the aim, not to save a life, but to enrich one. However, unlike most of these novel procedures – where one would be unlikely to find a willing living donor or an ethics committee that would sanction such a donation – the organs to be transplanted in UTx are potentially available from both living and deceased donors.In this paper, in light of the recent nine-case research trial in Sweden which used uteri obtained from living donors, and the assertions on the part of other research teams currently preparing trials that they will only be using deceased donors, I explore the question of whether, in the case of UTx, there existcompelling moral reasons to prefer the use of deceased donors despite the benefits that may be associated with the use of organs obtained from the living.
AB - In recent years much research has been undertaken regarding the feasibility of the human uterine transplant (UTx) as a treatment for absolute uterine factor infertility (AUFI). Should it reach clinical application this procedure would allow such individuals what is often a much-desired opportunity to become not only social mothers (via adoption or traditional surrogacy arrangements), or genetic and social mothers (through gestational surrogacy) but mothers in a social, genetic and gestational sense. Like many experimental transplantation procedures such as face, hand, corneal and larynx transplants, UTx as a therapeutic option falls firmly into the camp of the quality of life (QOL) transplant, undertaken with the aim, not to save a life, but to enrich one. However, unlike most of these novel procedures – where one would be unlikely to find a willing living donor or an ethics committee that would sanction such a donation – the organs to be transplanted in UTx are potentially available from both living and deceased donors.In this paper, in light of the recent nine-case research trial in Sweden which used uteri obtained from living donors, and the assertions on the part of other research teams currently preparing trials that they will only be using deceased donors, I explore the question of whether, in the case of UTx, there existcompelling moral reasons to prefer the use of deceased donors despite the benefits that may be associated with the use of organs obtained from the living.
KW - Uterine Transplants
KW - Quality of Life Transplants
KW - Autonomy
KW - Beneficence
KW - Non-Maleficence
KW - Transplantation Ethics
KW - Reproductive Ethics
U2 - 10.1111/bioe.12247
DO - 10.1111/bioe.12247
M3 - Journal article
VL - 30
SP - 415
EP - 424
JO - Bioethics
JF - Bioethics
SN - 0269-9702
IS - 6
ER -